Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
77.48 USD | -0.40% | -1.77% | +36.50% |
May. 31 | Roth MKM Upgrades LeMaitre Vascular to Buy Rating With $100 Price Target | MT |
May. 10 | Tranche Update on LeMaitre Vascular, Inc.'s Equity Buyback Plan announced on February 27, 2024. | CI |
Financials (USD)
Sales 2024 * | 215M | Sales 2025 * | 231M | Capitalization | 1.74B |
---|---|---|---|---|---|
Net income 2024 * | 40M | Net income 2025 * | 44M | EV / Sales 2024 * | 8.09 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 7.52 x |
P/E ratio 2024 * |
43.7
x | P/E ratio 2025 * |
39.7
x | Employees | 622 |
Yield 2024 * |
0.83% | Yield 2025 * |
0.85% | Free-Float | 84.65% |
Latest transcript on LeMaitre Vascular, Inc.
1 day | -0.40% | ||
1 week | -1.77% | ||
Current month | -1.77% | ||
1 month | +1.95% | ||
3 months | +15.30% | ||
6 months | +41.77% | ||
Current year | +36.50% |
Managers | Title | Age | Since |
---|---|---|---|
George LeMaitre
CEO | Chief Executive Officer | 59 | 92-05-31 |
David Roberts
PSD | President | 60 | 96-12-31 |
Director of Finance/CFO | 59 | 04-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Roush
BRD | Director/Board Member | 58 | 14-04-08 |
Director of Finance/CFO | 59 | 04-12-31 | |
John O'Connor
BRD | Director/Board Member | 76 | 08-09-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.96% | 11 M€ | -6.03% | - | |
0.45% | 28 M€ | -3.53% | ||
0.26% | 26 M€ | -4.59% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 77.48 | -0.40% | 89,248 |
24-06-06 | 77.79 | -3.28% | 142,817 |
24-06-05 | 80.43 | +3.89% | 151,583 |
24-06-04 | 77.42 | -1.44% | 131,631 |
24-06-03 | 78.55 | -0.42% | 126,463 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.50% | 1.74B | |
+9.48% | 222B | |
+13.72% | 195B | |
+23.79% | 148B | |
+33.39% | 113B | |
+4.75% | 66.45B | |
+3.16% | 50.03B | |
-4.35% | 38.8B | |
-1.27% | 34.85B | |
+22.61% | 30.98B |
- Stock Market
- Equities
- LMAT Stock